Le Lézard
Classified in: Health
Subject: FVT

Correction: Elev8 Brands, Inc. Announces Event For Art Week in Miami


ROCKLEDGE, Fla., Nov. 24, 2017 /PRNewswire/ -- Elev8 Brands, Inc. (OTC Pink: VATE), a holding company focused on the commercial development of hemp and CBD-based products including hemp coffee, tea, and E-juices, which target the health and wellness markets, in a collaborative effort with Kona Gold Solutions, Inc. (OTC Pink: KGKG), will have an event during Miami's Art Week. The event will bring premium hemp products to all visitors of Art Week and showcase new product launches from both companies: Elev8 Hemp's new Hemp Tea and Kona Gold's new Highdrate CBD Waters.

An earlier release mistakenly stated that Elev8 and Kona Gold were sponsors of the Art Basel show. Both Elev8 and Kona Gold regret any confusion caused by the prior announcement.

Kona Gold's CEO Robert Clark stated, "This is a fantastic event that we are excited to be a part of.  Miami's Art Week sees thousands of enthusiasts come through over the four-day event and we, along with the Elev8 team, are excited to be showcasing new products from both companies in such a great environment."

About Elev8 Brands, Inc.:
Elev8 Brands, Inc. specializes in the development and marketing of products for the fitness and wellness markets.  The company is founded based on creating high-quality, sustainable, products for health-conscious consumers. 

About Elev8 Hemp LLC:
Elev8 Hemp LLC is a wholly-owned subsidiary of Elev8 Brands, Inc. which focuses on the development and marketing of hemp-based food, beverage, and health care products including hemp coffee, hemp tea, and CBD Product.

About 02 Breathe LLC:
02 Breathe is a wholly-owned subsidiary of Elev8 Brands, Inc. which focuses on their oxygen bar while bringing in an array of CBD products. O2 Breathe carries CBD tinctures, CBD vape, CBD lotions and message products. 02 Breathe is currently looking to offer CBD at their oxygen bar.
www.02breathe.com

Please visit, www.elev8hemp.com for more information.
www.facebook.com/elev8hemp
www.instagram.com/elev8hemp
www.twitter.com/elev8hemp

Safe Harbor Statement:
The information posted in this release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by use of the words "may," "will," "should," "plans," "expects," "anticipates," "continue," "estimate," "project," "intend," and similar expressions. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected or anticipated. These risks and uncertainties include, but are not limited to, general economic and business conditions, effects of continued geopolitical unrest and regional conflicts, competition, changes in technology and methods of marketing, delays in completing various engineering and manufacturing programs, changes in customer order patterns, changes in product mix, continued success in technological advances and delivering technological innovations, shortages in components, production delays due to performance quality issues with outsourced components, and various other factors beyond the Company's control.

 

SOURCE Elev8 Brands, Inc.


These press releases may also interest you

at 10:30
The "Licensing Deals in Biotechnology 2019-2024" report has been added to ResearchAndMarkets.com's offering. Licensing Deals in Biotechnology provides a detailed understanding and analysis of how and why companies enter licensing deals. Fully...

at 10:30
The "Molecular Diagnostics for Cancer: Markets Forecasts by Cancer Type, Product, and Place with Executive & Consultant Guides and Customization. 2023 to 2027" report has been added to ResearchAndMarkets.com's offering. Exciting technical...

at 10:10
The group division of Ameritas proudly announces its 17th consecutive certification as a BenchmarkPortal Center of Excellence, solidifying its position as a leader in customer service and support excellence. This prestigious recognition for 2023...

at 10:05
The "Distribution Deals in Diagnostics 2016 to 2024" report has been added to ResearchAndMarkets.com's offering. Distribution Deals in Diagnostics provides a detailed understanding and analysis of how and why companies enter distribution deals....

at 10:00
Driving is the leading cause of work-related death each year in the United States, with nearly 40% of deaths on the job occurring on American roads according to the U.S. Bureau of Labor Statistics. A major contributing factor to road deaths each...

at 10:00
Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the recent launch of Methimazole Tablets, USP, 5 mg and 10 mg. The Methimazole Tablet market had U.S. sales of approximately $36.8 million for the 12 months ending December 2023 according...



News published on and distributed by: